These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22637364)

  • 1. Civil society and public health research in the European Union new member states.
    McCarthy M; Knabe A
    Scand J Public Health; 2012 May; 40(3):253-9. PubMed ID: 22637364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Civil society organisations and public health research--evidence from eight European union new member states.
    Knabe A; McCarthy M
    Cent Eur J Public Health; 2012 Dec; 20(4):287-93. PubMed ID: 23441396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Civil society organisations, social innovation and health research in Europe.
    Beinare D; McCarthy M
    Eur J Public Health; 2012 Dec; 22(6):889-93. PubMed ID: 22117053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What role can civil society organizations have in European health policy?
    Zeegers Paget D; Renshaw N; Droogers M
    Eur J Public Health; 2017 Oct; 27(suppl_4):52-55. PubMed ID: 29028234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Civil society engagement in innovation and research through the European Public Health Association.
    Zeegers Paget D; Barnhoorn F; McCarthy M; Alexanderson K; Conceição C; Devillé W; Grimaud O; Katreniakova Z; Narkauskaité L; Saliba A; Sammut M; Voss M
    Eur J Public Health; 2013 Nov; 23 Suppl 2():12-8. PubMed ID: 24189790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National support to public health research: a survey of European ministries.
    Conceição C; Leandro A; McCarthy M
    BMC Public Health; 2009 Jun; 9():203. PubMed ID: 19555492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECVAM'S activities in the EU candidate countries.
    Sladowski D; Halder M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():203-5. PubMed ID: 12513675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity and readiness of civil society organisations to implement community case management of malaria in Kenya.
    Marita E; Oule J; Mungai M; Thiam S; Ilako F
    Pan Afr Med J; 2016; 25(Suppl 2):6. PubMed ID: 28523081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for public health research in European Union countries.
    Grimaud O; McCarthy M; Conceição C
    Eur J Public Health; 2013 Nov; 23 Suppl 2():35-8. PubMed ID: 24189794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing governance models and funding mechanisms of state-civil society partnerships for HIV/AIDS treatment and prevention based on lessons from Ghana.
    Hushie M
    Afr J AIDS Res; 2019 Jul; 18(2):138-147. PubMed ID: 31282299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 15. Harm reduction in Europe: a framework for civil society-led monitoring.
    Rigoni R; Tammi T; van der Gouwe D; Schatz E
    Harm Reduct J; 2021 Jan; 18(1):3. PubMed ID: 33407566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future.
    O'Gorman A; Schatz E
    Harm Reduct J; 2021 Feb; 18(1):17. PubMed ID: 33568156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health research systems in the European union.
    Conceição C; McCarthy M
    Health Res Policy Syst; 2011 Oct; 9():38. PubMed ID: 21970897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital reforms in 11 Central and Eastern European countries between 2008 and 2019: a comparative analysis.
    Dubas-Jakóbczyk K; Albreht T; Behmane D; Bryndova L; Dimova A; Džakula A; Habicht T; Murauskiene L; Scîntee SG; Smatana M; Velkey Z; Quentin W
    Health Policy; 2020 Apr; 124(4):368-379. PubMed ID: 32113666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of civil society organizations (CSOs) in antimicrobial resistance (AMR) mitigation efforts in low- and middle-income countries: A report from India.
    Ranganathan R; Ranjalkar J
    J Infect Public Health; 2023 Dec; 16 Suppl 1():125-128. PubMed ID: 37973495
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.